Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival.
暂无分享,去创建一个
Xudong Dai | Chenchen Yang | Muneesh Tewari | Jun Zhu | Hong Wang | Carmen Behrens | Ignacio I Wistuba | Qing Zhang | S. Hanash | Jun Zhu | J. Thiery | I. Wistuba | Kavita S Garg | E. Kroh | M. Tewari | A. Gazdar | C. Behrens | Chee-Hong Wong | I. Laird-Offringa | M. Schliekelman | Hong Wang | Alice Chin | A. Taguchi | Qing Zhang | Lisa G. McFerrin | Jaime Rodriguez | S. Selamat | Chenchen Yang | Adi F Gazdar | Muge Celiktas | Alice Chin | Chee-Hong Wong | Samir M Hanash | Xudong Dai | Ayumu Taguchi | Ite A Laird-Offringa | Mark J Schliekelman | Jaime Rodriguez | Muge Celiktas | Lisa McFerrin | Suhaida A Selamat | Evan M Kroh | Jean P Thiery | Suhaida A. Selamat | Chee‐Hong Wong
[1] V. Keshamouni,et al. Epithelial-mesenchymal transition in tumor metastasis: a method to the madness. , 2009, Future oncology.
[2] E. Lander,et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[3] Eshel Ben-Jacob,et al. MicroRNA-based regulation of epithelial–hybrid–mesenchymal fate determination , 2013, Proceedings of the National Academy of Sciences.
[4] Caicun Zhou,et al. Clinicopathological features and epidermal growth factor receptor mutations associated with epithelial–mesenchymal transition in non‐small cell lung cancer , 2009, Respirology.
[5] G. Hampton,et al. DNA Methylation Profiling Defines Clinically Relevant Biological Subsets of Non–Small Cell Lung Cancer , 2012, Clinical Cancer Research.
[6] A. Feinberg,et al. Genome-scale epigenetic reprogramming during epithelial to mesenchymal transition , 2011, Nature Structural &Molecular Biology.
[7] A. Dimmler,et al. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. , 2008, Cancer research.
[8] D G Wilkinson,et al. Control of cell behavior during vertebrate development by Slug, a zinc finger gene. , 1994, Science.
[9] Jing Yang,et al. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. , 2012, Cancer cell.
[10] T. Lecuit,et al. Breaking down EMT , 2008, Nature Cell Biology.
[11] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[12] HighWire Press,et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. , 1983 .
[13] R. Huang,et al. Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.
[14] Elizabeth Garrett-Mayer,et al. ZEB1-responsive genes in non-small cell lung cancer. , 2011, Cancer letters.
[15] Igor Jurisica,et al. Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study , 2008, Nature Medicine.
[16] E. Hay,et al. Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. , 2005, Cells, tissues, organs.
[17] Robert A. Weinberg,et al. The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.
[18] I. Gelman,et al. Pivotal Role of AKAP12 in the Regulation of Cellular Adhesion Dynamics: Control of Cytoskeletal Architecture, Cell Migration, and Mitogenic Signaling , 2012, Journal of signal transduction.
[19] S. Dedhar,et al. The Role of Epithelial– Mesenchymal Transition in Cancer Metastasis , 2015 .
[20] J. Thiery,et al. Epithelium‐mesenchyme interconversion as example of epithelial plasticity , 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[21] R. Beroukhim,et al. Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.
[22] Gerhard Christofori,et al. EMT, the cytoskeleton, and cancer cell invasion , 2009, Cancer and Metastasis Reviews.
[23] D. Nanba,et al. Changes in adhesive properties of epithelial cells during early morphogenesis of the mammary gland , 2001, Development, growth & differentiation.
[24] Diane D. Liu,et al. Epithelial-to-Mesenchymal Transition in the Development and Progression of Adenocarcinoma and Squamous Cell Carcinoma of the Lung , 2009, Modern Pathology.
[25] Keitaro Matsuo,et al. Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] B. Rubino,et al. The role of epithelial-mesenchymal transition in cancer pathology. , 2007, Pathology.
[27] Sun-Mi Park,et al. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.
[28] I. Fidler,et al. Biological heterogeneity of cancer , 2012, Human vaccines & immunotherapeutics.
[29] Michael Peyton,et al. An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance , 2012, Clinical Cancer Research.
[30] J. Rossant,et al. FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. , 2001, Developmental cell.
[31] E. Hay,et al. Transforming Growth Factor-β Signaling during Epithelial-Mesenchymal Transformation: Implications for Embryogenesis and Tumor Metastasis , 2005, Cells Tissues Organs.
[32] J. Clements,et al. Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression , 2007, Journal of cellular physiology.
[33] R. Nusse,et al. Convergence of Wnt, ß-Catenin, and Cadherin Pathways , 2004, Science.
[34] Héctor Peinado,et al. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.
[35] Raghu Kalluri,et al. The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.
[36] Christopher A. Maher,et al. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial–mesenchymal transition , 2011, The Journal of cell biology.
[37] H. Trompeter,et al. Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells , 2010, BMC Research Notes.
[38] Jayanta Debnath,et al. Modelling glandular epithelial cancers in three-dimensional cultures , 2005, Nature Reviews Cancer.
[39] M. Herlyn,et al. Comparative Secretome Analysis of Epithelial and Mesenchymal Subpopulations of Head and Neck Squamous Cell Carcinoma Identifies S100A4 as a Potential Therapeutic Target* , 2013, Molecular & Cellular Proteomics.
[40] David Dunson,et al. Genetic heterogeneity of diffuse large B-cell lymphoma , 2013, Proceedings of the National Academy of Sciences.
[41] Lan Xu,et al. miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells* , 2010, The Journal of Biological Chemistry.
[42] E. Yi,et al. Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung. , 2012, Histology and histopathology.
[43] Richard Simon,et al. Gene expression-based prognostic signatures in lung cancer: ready for clinical use? , 2010, Journal of the National Cancer Institute.
[44] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[45] M. Esteller,et al. Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis , 2011, Oncogene.
[46] A. Johansson,et al. A CD44high/EGFRlow Subpopulation within Head and Neck Cancer Cell Lines Shows an Epithelial-Mesenchymal Transition Phenotype and Resistance to Treatment , 2012, PloS one.
[47] R. Nusse,et al. Convergence of Wnt, beta-catenin, and cadherin pathways. , 2004, Science.
[48] M. Mann,et al. A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC) , 2006, Nature Protocols.
[49] H. Beug,et al. Molecular requirements for epithelial-mesenchymal transition during tumor progression. , 2005, Current opinion in cell biology.
[50] Yong Soo Choi,et al. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[51] M. Thiry,et al. Evidence for a partial epithelial–mesenchymal transition in postnatal stages of rat auditory organ morphogenesis , 2012, Histochemistry and Cell Biology.
[52] R. Foisner,et al. The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity , 2007, Oncogene.
[53] Sabine Tejpar,et al. Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer , 2013, The Journal of pathology.
[54] Kwon-Sik Park,et al. Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. , 2011, Cancer cell.